Skip to main content
Top
Published in: Trials 1/2018

Open Access 01-12-2018 | Study protocol

The role of exercise combined with tocilizumab in visceral and epicardial adipose tissue and gastric emptying rate in abdominally obese participants: protocol for a randomised controlled trial

Authors: Regitse Højgaard Christensen, Anne-Sophie Wedell-Neergaard, Louise Lang Lehrskov, Grit Elster Legård, Emma Berndt Dorph, Stine Nymand, Maria Korf Ball, Morten Zacho, Robin Christensen, Helga Ellingsgaard, Jaya Birgitte Rosenmeier, Rikke Krogh-Madsen, Bente Klarlund Pedersen, Kristian Karstoft

Published in: Trials | Issue 1/2018

Login to get access

Abstract

Background

Exercise reduces the amount of visceral adipose tissue (VAT) and the risk of cardiometabolic diseases. The underlying mechanisms responsible for these exercise-induced adaptations are unclear, but they may involve lipolytic actions of interleukin-6 (IL-6). Contracting skeletal muscles secrete IL-6, leading to increased circulating IL-6 levels in response to exercise. The aim of this study is to investigate whether IL-6 is involved in mediating the effects of exercise on visceral and epicardial adipose tissue volume and glycaemic control.

Methods/design

Seventy-five physically inactive males and females aged > 18 years with a waist-to-height ratio > 0.5 and/or waist circumference ≥ 88 cm (females) or ≥ 102 cm (males) are being recruited to participate in a 12-week intervention study. Participants are randomly allocated to one of five groups (1:1:1:1:1). Two groups consist of supervised endurance exercise training combined with the IL-6 blocker tocilizumab (ET) or saline used as placebo (EP), two groups consist of no exercise combined with tocilizumab (NT) or placebo (NP), and one group consists of resistance exercise and placebo (RP). Although the study is an exploratory trial, the primary outcome is change in VAT volume from before to after intervention, with secondary outcomes being changes in (1) epicardial adipose tissue, (2) pericardial adipose tissue and (3) gastric emptying. Depots of adipose tissue are quantitated by magnetic resonance imaging Gastric emptying and glucose metabolism are assessed using mixed-meal tolerance tests.

Discussion

Understanding the role of IL-6 in mediating the effects of exercise on visceral and epicardial adipose tissue and glycaemic control may lead to novel therapeutic approaches in the prevention of cardiometabolic diseases.

Trial registration

ClinicalTrials.gov, NCT02901496. Registered on 1 August 2016 and posted retrospectively on 15 September 2016.
Appendix
Available only for authorised users
Literature
1.
go back to reference Pedersen BK. The anti-inflammatory effect of exercise: its role in diabetes and cardiovascular disease control. Essays Biochem. 2006;42:105–17.CrossRefPubMed Pedersen BK. The anti-inflammatory effect of exercise: its role in diabetes and cardiovascular disease control. Essays Biochem. 2006;42:105–17.CrossRefPubMed
2.
go back to reference Noyes AM, Dua K, Devadoss R, et al. Cardiac adipose tissue and its relationship to diabetes mellitus and cardiovascular disease. World J Diabetes. 2014;5:868–76.CrossRefPubMedPubMedCentral Noyes AM, Dua K, Devadoss R, et al. Cardiac adipose tissue and its relationship to diabetes mellitus and cardiovascular disease. World J Diabetes. 2014;5:868–76.CrossRefPubMedPubMedCentral
4.
go back to reference Vissers D, Hens W, Taeymans J, et al. The effect of exercise on visceral adipose tissue in overweight adults: a systematic review and meta-analysis. PLoS One. 2013;8:e56415.CrossRefPubMedPubMedCentral Vissers D, Hens W, Taeymans J, et al. The effect of exercise on visceral adipose tissue in overweight adults: a systematic review and meta-analysis. PLoS One. 2013;8:e56415.CrossRefPubMedPubMedCentral
5.
go back to reference Ross R, Dagnone D, Jones PJH, et al. Diet-induced weight loss or exercise-induced weight loss in men. Ann Intern Med. 2000;133:92–103.CrossRefPubMed Ross R, Dagnone D, Jones PJH, et al. Diet-induced weight loss or exercise-induced weight loss in men. Ann Intern Med. 2000;133:92–103.CrossRefPubMed
6.
go back to reference Holloszy JO. Exercise-induced increase in muscle insulin sensitivity. J Appl Physiol. 2005;99:338–43.CrossRefPubMed Holloszy JO. Exercise-induced increase in muscle insulin sensitivity. J Appl Physiol. 2005;99:338–43.CrossRefPubMed
7.
go back to reference Peterson AM, Pedersen BK. The role of IL-6 in mediating the anti-inflammatory effects of exercise. J Physiol Pharmacol. 2006;57:43–51. Peterson AM, Pedersen BK. The role of IL-6 in mediating the anti-inflammatory effects of exercise. J Physiol Pharmacol. 2006;57:43–51.
8.
go back to reference Petersen EW, Carey AL, Sacchetti M, et al. Acute IL-6 treatment increases fatty acid turnover in elderly humans in vivo and in tissue culture in vitro. Am J Physiol Endocrinol Metab. 2005;288:E155–62.CrossRefPubMed Petersen EW, Carey AL, Sacchetti M, et al. Acute IL-6 treatment increases fatty acid turnover in elderly humans in vivo and in tissue culture in vitro. Am J Physiol Endocrinol Metab. 2005;288:E155–62.CrossRefPubMed
9.
go back to reference Kim MK. Aerobic exercise training reduces epicardial fat in obese men. J Appl Physiol. 2008;106:5–11.CrossRefPubMed Kim MK. Aerobic exercise training reduces epicardial fat in obese men. J Appl Physiol. 2008;106:5–11.CrossRefPubMed
10.
go back to reference Ellingsgaard H, Hauselmann I, Schuler B, et al. Interleukin-6 enhances insulin secretion by increasing glucagon-like peptide-1 secretion from L cells and alpha cells. Nat Med. 2011;17:1481–9.CrossRefPubMedPubMedCentral Ellingsgaard H, Hauselmann I, Schuler B, et al. Interleukin-6 enhances insulin secretion by increasing glucagon-like peptide-1 secretion from L cells and alpha cells. Nat Med. 2011;17:1481–9.CrossRefPubMedPubMedCentral
12.
go back to reference Holst JJ, Gribble F, Horowitz M, et al. Roles of the gut in glucose homeostasis. Diabetes Care. 2016;39:884–92.CrossRefPubMed Holst JJ, Gribble F, Horowitz M, et al. Roles of the gut in glucose homeostasis. Diabetes Care. 2016;39:884–92.CrossRefPubMed
13.
go back to reference Donges CE, Duffield R, Drinkwater EJ. Effects of resistance or aerobic exercise training on interleukin-6, C-reactive protein, and body composition. Med Sci Sport Exerc. 2010;42:304–13.CrossRef Donges CE, Duffield R, Drinkwater EJ. Effects of resistance or aerobic exercise training on interleukin-6, C-reactive protein, and body composition. Med Sci Sport Exerc. 2010;42:304–13.CrossRef
14.
go back to reference Olson TP, Dengel DR, Leon AS, et al. Changes in inflammatory biomarkers following one-year of moderate resistance training in overweight women. Int J Obes. 2007;31:996–1003.CrossRef Olson TP, Dengel DR, Leon AS, et al. Changes in inflammatory biomarkers following one-year of moderate resistance training in overweight women. Int J Obes. 2007;31:996–1003.CrossRef
15.
go back to reference Osei K, Gaillard T. Disparities in cardiovascular disease and type 2 diabetes risk factors in blacks and whites: dissecting racial paradox of metabolic syndrome. Front Endocrinol (Lausanne). 2017;8:204.CrossRef Osei K, Gaillard T. Disparities in cardiovascular disease and type 2 diabetes risk factors in blacks and whites: dissecting racial paradox of metabolic syndrome. Front Endocrinol (Lausanne). 2017;8:204.CrossRef
16.
go back to reference Pedersen BK, Febbraio MA. Muscles, exercise and obesity: skeletal muscle as a secretory organ. Nat Rev Endocrinol. 2012;8:457–65.CrossRefPubMed Pedersen BK, Febbraio MA. Muscles, exercise and obesity: skeletal muscle as a secretory organ. Nat Rev Endocrinol. 2012;8:457–65.CrossRefPubMed
17.
go back to reference Pedersen BK. Anti-inflammatory effects of exercise: role in diabetes and cardiovascular disease. Eur J Clin Investig. 2017;47:600–11.CrossRef Pedersen BK. Anti-inflammatory effects of exercise: role in diabetes and cardiovascular disease. Eur J Clin Investig. 2017;47:600–11.CrossRef
19.
go back to reference Vega GL, Adams-Huet B, Peshock R, et al. Influence of body fat content and distribution on variation in metabolic risk. J Clin Endocrinol Metab. 2006;91:4459–66.CrossRefPubMed Vega GL, Adams-Huet B, Peshock R, et al. Influence of body fat content and distribution on variation in metabolic risk. J Clin Endocrinol Metab. 2006;91:4459–66.CrossRefPubMed
20.
go back to reference Tremblay MS, Aubert S, Barnes JD, et al. Sedentary Behavior Research Network (SBRN) – Terminology Consensus Project process and outcome. Int J Behav Nutr Phys Act. 2017;14:75.CrossRefPubMedPubMedCentral Tremblay MS, Aubert S, Barnes JD, et al. Sedentary Behavior Research Network (SBRN) – Terminology Consensus Project process and outcome. Int J Behav Nutr Phys Act. 2017;14:75.CrossRefPubMedPubMedCentral
21.
go back to reference Garber CE, Blissmer B, Deschenes MR, et al. Quantity and quality of exercise for developing and maintaining cardiorespiratory, musculoskeletal, and neuromotor fitness in apparently healthy adults: guidance for prescribing exercise. Med Sci Sports Exerc. 2011;43:1334–59.CrossRefPubMed Garber CE, Blissmer B, Deschenes MR, et al. Quantity and quality of exercise for developing and maintaining cardiorespiratory, musculoskeletal, and neuromotor fitness in apparently healthy adults: guidance for prescribing exercise. Med Sci Sports Exerc. 2011;43:1334–59.CrossRefPubMed
22.
go back to reference Sedentary Behaviour Research Network (SBRN). Letter to the editor: Standardized use of the terms ‘sedentary’ and ‘sedentary behaviours’. Ment Health Phys Act. 2013;6:55–6.CrossRef Sedentary Behaviour Research Network (SBRN). Letter to the editor: Standardized use of the terms ‘sedentary’ and ‘sedentary behaviours’. Ment Health Phys Act. 2013;6:55–6.CrossRef
23.
go back to reference Wattanapisit A, Thanamee S. Evidence behind 10,000 steps walking. J Health Res. 2017;31:241–8. Wattanapisit A, Thanamee S. Evidence behind 10,000 steps walking. J Health Res. 2017;31:241–8.
25.
go back to reference Smolen JS, Beaulieu A, Rubbert-Roth A, et al. Effect of interleukin-6 receptor inhibition with tocilizumab in patients with rheumatoid arthritis (OPTION study): a double-blind, placebo-controlled, randomised trial. Lancet. 2008;371:987–97.CrossRefPubMed Smolen JS, Beaulieu A, Rubbert-Roth A, et al. Effect of interleukin-6 receptor inhibition with tocilizumab in patients with rheumatoid arthritis (OPTION study): a double-blind, placebo-controlled, randomised trial. Lancet. 2008;371:987–97.CrossRefPubMed
26.
go back to reference Lancaster J, Ghiatas A, Alyassin A, et al. Measurement of abdominal fat with T1-weighted MR images. J Magn Reson Imaging. 1991;1:363–9.CrossRefPubMed Lancaster J, Ghiatas A, Alyassin A, et al. Measurement of abdominal fat with T1-weighted MR images. J Magn Reson Imaging. 1991;1:363–9.CrossRefPubMed
27.
go back to reference Positano V, Gastaldelli A, Sironi AM, et al. An accurate and robust method for unsupervised assessment of abdominal fat by MRI. J Magn Reson Imaging. 2004;20:684–9.CrossRefPubMed Positano V, Gastaldelli A, Sironi AM, et al. An accurate and robust method for unsupervised assessment of abdominal fat by MRI. J Magn Reson Imaging. 2004;20:684–9.CrossRefPubMed
28.
go back to reference Heading R, Nimmo J, Prescott L, et al. The dependence of paracetamol absorption on the rate of gastric emptying. Br J Pharmac. 1973;47:415–21.CrossRef Heading R, Nimmo J, Prescott L, et al. The dependence of paracetamol absorption on the rate of gastric emptying. Br J Pharmac. 1973;47:415–21.CrossRef
29.
30.
go back to reference Ware JH. Interpreting incomplete data in studies of diet and weight loss. N Engl J Med. 2003;348:2136–7.CrossRefPubMed Ware JH. Interpreting incomplete data in studies of diet and weight loss. N Engl J Med. 2003;348:2136–7.CrossRefPubMed
31.
go back to reference Moher D, Hopewell S, Schulz KF, et al. CONSORT 2010 explanation and elaboration: updated guidelines for reporting parallel group randomised trials. Int J Surg. 2012;10:28–55.CrossRefPubMed Moher D, Hopewell S, Schulz KF, et al. CONSORT 2010 explanation and elaboration: updated guidelines for reporting parallel group randomised trials. Int J Surg. 2012;10:28–55.CrossRefPubMed
32.
go back to reference Christensen R, Bliddal H, Henriksen M. Enhancing the reporting and transparency of rheumatology research: a guide to reporting guidelines. Arthritis Res Ther. 2013;15:109.CrossRefPubMedPubMedCentral Christensen R, Bliddal H, Henriksen M. Enhancing the reporting and transparency of rheumatology research: a guide to reporting guidelines. Arthritis Res Ther. 2013;15:109.CrossRefPubMedPubMedCentral
34.
go back to reference Karstoft K, Winding K, Knudsen SH, et al. The effects of free-living interval-walking training on glycemic control, body composition, and physical fitness in type 2 diabetic patients. Diabetes Care. 2013;36:228–36.CrossRefPubMedPubMedCentral Karstoft K, Winding K, Knudsen SH, et al. The effects of free-living interval-walking training on glycemic control, body composition, and physical fitness in type 2 diabetic patients. Diabetes Care. 2013;36:228–36.CrossRefPubMedPubMedCentral
35.
go back to reference Lindegaard B, Hansen T, Hvid T, et al. The effect of strength and endurance training on insulin sensitivity and fat distribution in human immunodeficiency virus-infected patients with lipodystrophy. J Clin Endocrinol Metab. 2008;93:3860–9.CrossRefPubMed Lindegaard B, Hansen T, Hvid T, et al. The effect of strength and endurance training on insulin sensitivity and fat distribution in human immunodeficiency virus-infected patients with lipodystrophy. J Clin Endocrinol Metab. 2008;93:3860–9.CrossRefPubMed
36.
go back to reference Helgerud J, Høydal K, Wang E, et al. Aerobic high-intensity intervals improve V̇O2max more than moderate training. Med Sci Sports Exerc. 2007;39:665–71.CrossRefPubMed Helgerud J, Høydal K, Wang E, et al. Aerobic high-intensity intervals improve V̇O2max more than moderate training. Med Sci Sports Exerc. 2007;39:665–71.CrossRefPubMed
37.
go back to reference World Medical Association. World Medical Association Declaration of Helsinki Ethical Principles for Medical Research Involving Human Subjects. JAMA. 2013;310:2191–4.CrossRef World Medical Association. World Medical Association Declaration of Helsinki Ethical Principles for Medical Research Involving Human Subjects. JAMA. 2013;310:2191–4.CrossRef
38.
Metadata
Title
The role of exercise combined with tocilizumab in visceral and epicardial adipose tissue and gastric emptying rate in abdominally obese participants: protocol for a randomised controlled trial
Authors
Regitse Højgaard Christensen
Anne-Sophie Wedell-Neergaard
Louise Lang Lehrskov
Grit Elster Legård
Emma Berndt Dorph
Stine Nymand
Maria Korf Ball
Morten Zacho
Robin Christensen
Helga Ellingsgaard
Jaya Birgitte Rosenmeier
Rikke Krogh-Madsen
Bente Klarlund Pedersen
Kristian Karstoft
Publication date
01-12-2018
Publisher
BioMed Central
Published in
Trials / Issue 1/2018
Electronic ISSN: 1745-6215
DOI
https://doi.org/10.1186/s13063-018-2637-0

Other articles of this Issue 1/2018

Trials 1/2018 Go to the issue